Pure Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-01-2025
- Paid Up Capital ₹ 0.80 M
as on 11-01-2025
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.59 Cr
as on 11-01-2025
- Revenue 33.05%
(FY 2023)
- Profit -45.72%
(FY 2023)
- Ebitda -41.65%
(FY 2023)
- Net Worth 0.38%
(FY 2023)
- Total Assets -32.50%
(FY 2023)
About Pure Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.80 M.
The company has closed loans amounting to ₹1.59 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Franklin Fernandes and Manoj Mehta serve as directors at the Company.
- CIN/LLPIN
U24100MH2009PTC192062
- Company No.
192062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pure Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Franklin Fernandes  | Director | Current | |
| Manoj Mehta | Director | 27-Apr-2009 | Current |
Financial Performance of Pure Life Science.
Pure Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.05% increase. The company also saw a substantial fall in profitability, with a 45.72% decrease in profit. The company's net worth moved up by a moderate rise of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pure Life Science?
Unlock access to Pure Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vfm Pharma Private LimitedActive 13 years 6 monthsFranklin Fernandes and Manoj Mehta are mutual person
- Aquila Healthcare Private LimitedActive 14 years 3 months
Franklin Fernandes and Manoj Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Apr 2016 | ₹3.90 M | Satisfied |
Janata Sahakari Bank Ltd Pune Creation Date: 31 Oct 2013 | ₹6.00 M | Satisfied |
Janata Sahakari Bank Ltd Pune Creation Date: 30 Oct 2013 | ₹6.00 M | Satisfied |
How Many Employees Work at Pure Life Science?
Unlock and access historical data on people associated with Pure Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pure Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pure Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
